News

KE Holdings Inc. Unveils Its Comprehensive ESG Strategy for 2024

KE Holdings Inc. Unveils Its Comprehensive ESG Strategy for 2024

KE Holdings Inc. Paving the Way for Sustainable Housing

KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE; HKEX: 2423), recognized as a leader in the housing transaction sector, recently released its 2024 Environmental, Social and Governance (ESG) report. This document not only highlights the company's commitment to sustainability but also showcases its strategic initiatives designed to enhance service quality and empower its industry partners.

Focus on People and Trust

Mr. Stanley Yongdong Peng, Beike's Co-founder and CEO, emphasized the importance of consumer trust and satisfaction in today's evolving residential service landscape. Beike aims to create a collaborative environment that builds a healthier ecosystem, encouraging sustainable growth and progress for all stakeholders involved.

Understanding the 2024 ESG Report

The 2024 ESG Report encapsulates Beike’s achievements in corporate governance, talent development, service quality, and environmental sustainability. These initiatives aim to deliver shared value while positively influencing all parties connected to the company.

Key Achievements in Corporate Governance

Beike continues to promote a transparent business approach, increasing information security measures to foster sustainable expansion. To ensure accountability, the company integrated sustainability goals into senior management’s performance reviews, reinforcing long-term ESG progress. A notable assessment conducted by Beike involved double materiality, identifying significant ESG impacts from both financial and societal perspectives, thereby steering its Sustainable Development Strategy.

Enhancing Service Quality

The company is committed to establishing a cycle of high-quality service and customer satisfaction. To cater to the changing consumer landscape, Beike launched the "3+3" service commitments applicable across its brokerage brands. This initiative includes the establishment of a substantial RMB100 million compensation fund aimed at protecting consumer rights and fortifying service provider security.

Support for Service Provider Development

Professional growth among service providers is vital to Beike’s mission. In 2024, training programs were implemented resulting in comprehensive engagement across its real estate agent network, where agents received an average of 109 hours of training. Additionally, the 'Erudite Examination' was further expanded to cover new sectors like home renovation and rentals, yielding nearly 3.2 million participations in 2024 alone.

Leveraging Technology for Service Improvement

Beike is at the forefront of utilizing advanced technologies to enhance user experiences and operational efficiencies. The launch of the "Beike Immersion" solution showcases how the company facilitates improved construction quality control and overall customer satisfaction. Smart technologies, including the Elderly Guardian initiative, are also making strides in home rental services, ensuring safety for vulnerable residents.

Commitment to Low-Carbon Strategies

To align with global green development initiatives, Beike has embedded environmentally friendly principles into every facet of its business operations. The introduction of the "Lianjia Green Store Standard" signifies the company's proactive approach to energy conservation, focusing on sustainable building practices and resource recycling.

Accessibility of the 2024 ESG Report

The comprehensive 2024 ESG Report can be accessed in both English and Chinese. For environmental considerations, Beike encourages viewing the electronic version available on their investor relations website.

About KE Holdings Inc.

Established as a premier integrated platform for housing transactions and services, KE Holdings Inc. has redefined how customers and service providers interact in the real estate sphere. With over 23 years of experience through its leading brand, Lianjia, Beike is adept at creating efficient frameworks for various housing needs including sales, rentals, and renovations.

Frequently Asked Questions

What is the primary focus of KE Holdings Inc.'s 2024 ESG Report?

The 2024 ESG Report primarily focuses on the company's initiatives in environmental sustainability, service quality enhancement, and corporate governance.

How does Beike ensure quality service for its clients?

Beike ensures quality service through the introduction of the "3+3" service commitments and the establishment of a compensation fund for consumer protection.

What training initiatives has Beike established for service providers?

Beike has created extensive training programs covering various sectors to support the professional development of service providers, focusing on comprehensive training for real estate agents.

How is Beike improving safety and quality in home services?

Beike leverages technology with initiatives like the "Beike Immersion" for construction quality control and the Elderly Guardian program for enhancing safety in home rentals.

What are Beike's commitments toward environmental sustainability?

Beike is committed to integrating eco-friendly practices throughout its operations, focusing on energy conservation and the Lianjia Green Store Standard to support a low-carbon future.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Embla Medical hf Reports Strong Q2 2025 Financial Performance

Updated Category News Views 203

Embla Medical hf's Interim Report for Q2 2025 Announcement No. 33/2025 Interim Report Q2 2025 Embla Medical hf has recently published its interim report for the second quarter of 2025, revealing encouraging financial results. The organization remains committed to enhancing mobility solutions through innovative offerings in prosthetics and orthotics. Strong Sales Growth...

Continue Reading
Fly-E Group Faces Important Class Action Deadline for Investors

Updated Category News Views 185

Fly-E Group Update: Important Class Action Deadline Attention investors of Fly-E Group, Inc. If you purchased securities between July 15 and August 14, 2025, this is vital news for you. As we approach a crucial lead plaintiff deadline on November 10, 2025, the time to act is now. Understanding the Class Action The upcoming class action lawsuit revolves around Fly-E's...

Continue Reading
Royal Unibrew Posts Impressive Earnings Growth in Q3 2024

Updated Category News Views 173

Royal Unibrew's Remarkable Performance in Q3 2024 Royal Unibrew has demonstrated exceptional growth during the third quarter of 2024. The key highlights from this trading statement reveal a robust progression in organic volume and net revenue, paving the way for a bright future for the company. Strong Growth Metrics Organic Volume and Revenue Increases During Q3 2024,...

Continue Reading
Examining Medtronic PLC's Short Selling Trends and Insights

Updated Category News Views 184

Understanding Medtronic PLC's Short Interest Medtronic PLC (NYSE: MDT) has recently experienced a significant rise in its short interest as a percentage of float, currently at 17.56%. This increase signals a growing concern among investors, as the total number of shares sold short has reached 19.72 million, accounting for 1.54% of all available shares for trading. With...

Continue Reading
Palatin Technologies Announces Breakthrough in Obesity Management

Updated Category News Views 138

Positive Developments in Appetite Suppression Research Palatin Technologies, Inc. (NYSE American: PTN), a leading biopharmaceutical firm known for pioneering medications based on the melanocortin receptor system, has recently reported encouraging results concerning appetite suppression from its Phase 2 obesity study involving bremelanotide and tirzepatide. This...

Continue Reading